ANDAs Get More Time – Or Maybe Less – To Correct Minor Deficiencies
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA final guidance says sponsors will have seven calendar days to fix small application flaws instead of five business days; industry had wanted 10 business days.
You may also be interested in...
US FDA Outlines Internal ANDA Refuse-To-Receive Policy
Manual of Policies and Procedures document should provide more help to sponsors on what items must be in an ANDA for it to be reviewed.
US FDA Outlines Internal ANDA Refuse-To-Receive Policy
Manual of Policies and Procedures document should provide more help to sponsors on what items must be in an ANDA for it to be reviewed.
US FDA Largely Stands Pat In Revised ANDA Submission Guidance
Agency made few of industry's requested changes regarding when it would refuse to receive generic applications, but the absence of comments from several big generics companies indicates some level of satisfaction.